(WAY) Waystar Holding Common Stock - Overview
Sector: Healthcare | Industry: Health Information Services | Exchange: NASDAQ (USA) | Market Cap: 3.719m USD | Total Return: -49.9% in 12m
Avg Turnover: 47.9M
Qual. Beats: 0
Rev. Trend: 99.8%
Qual. Beats: 0
Warnings
Altman Z'' 0.48 < 1.0 - financial distress zone
Below Avwap Earnings
Tailwinds
No distinct edge detected
Waystar Holding Corp. (WAY) operates a cloud-based software-as-a-service (SaaS) platform designed to automate healthcare payment cycles. The company’s technology facilitates financial clearance, claim management, denial prevention, and revenue capture for healthcare providers. Headquartered in Lehi, Utah, the firm focuses on reducing administrative friction between providers and payers.
The healthcare technology sector increasingly relies on interoperability to manage complex billing codes and regulatory requirements. Waystar’s business model utilizes a recurring revenue structure, typical for enterprise software providers aiming to improve clinical integrity and reporting accuracy. Detailed historical performance metrics for this ticker are available on ValueRay for those conducting deeper due diligence.
- Cloud-based software adoption accelerates healthcare revenue cycle digitization
- Expansion of health system provider network drives recurring subscription revenue
- Regulatory changes in healthcare reimbursement complexity increase demand for analytics
- Strategic acquisitions expand total addressable market within medical payment processing
- High interest rates impact valuation multiples for high-growth SaaS platforms
| Net Income: 126.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.79 > 1.0 |
| NWC/Revenue: 14.41% < 20% (prev 30.69%; Δ -16.28% < -1%) |
| CFO/TA 0.06 > 3% & CFO 330.3m > Net Income 126.1m |
| Net Debt (1.33b) to EBITDA (429.2m): 3.11 < 3 |
| Current Ratio: 1.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (195.2m) vs 12m ago 8.00% < -2% |
| Gross Margin: 65.22% > 18% (prev 0.67%; Δ 6.46k% > 0.5%) |
| Asset Turnover: 22.12% > 50% (prev 21.11%; Δ 1.01% > 0%) |
| Interest Coverage Ratio: 3.51 > 6 (EBITDA TTM 429.2m / Interest Expense TTM 79.9m) |
| A: 0.03 (Total Current Assets 386.6m - Total Current Liabilities 220.0m) / Total Assets 5.84b |
| B: -0.01 (Retained Earnings -65.5m / Total Assets 5.84b) |
| C: 0.05 (EBIT TTM 280.6m / Avg Total Assets 5.23b) |
| D: -0.03 (Book Value of Equity -62.8m / Total Liabilities 1.90b) |
| Altman-Z'' = 0.48 = B |
| DSRI: 0.99 (Receivables 172.5m/147.3m, Revenue 1.16b/975.2m) |
| GMI: 1.02 (GM 65.22% / 66.79%) |
| AQI: 1.03 (AQ_t 0.92 / AQ_t-1 0.89) |
| SGI: 1.19 (Revenue 1.16b / 975.2m) |
| TATA: -0.03 (NI 126.1m - CFO 330.3m) / TA 5.84b) |
| Beneish M = -2.90 (Cap -4..+1) = A |
As of June 01, 2026, the stock is trading at USD 19.91 with a total of 2,081,489 shares traded.
Over the past week, the price has changed by +5.71%,
over one month by -6.85%,
over three months by -24.15% and
over the past year by -49.94%.
Waystar Holding Common Stock has received a consensus analysts rating of 4.69. Therefore, it is recommended to buy WAY.
- StrongBuy: 9
- Buy: 4
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 34.3 | 72.1% |
P/E Trailing = 28.9403
P/E Forward = 11.5741
P/S = 3.2154
P/B = 0.9446
Revenue TTM = 1.16b USD
EBIT TTM = 280.6m USD
EBITDA TTM = 429.2m USD
Long Term Debt = 1.46b USD (from longTermDebt, last quarter)
Short Term Debt = 19.8m USD (from shortTermDebt, last quarter)
Debt = 1.49b USD (corrected: LT Debt 1.46b + ST Debt 19.8m) + Leases 16.5m
Net Debt = 1.33b USD (calculated: Debt 1.49b - CCE 158.9m)
Enterprise Value = 5.05b USD (3.72b + Debt 1.49b - CCE 158.9m)
Interest Coverage Ratio = 3.51 (Ebit TTM 280.6m / Interest Expense TTM 79.9m)
EV/FCF = 17.19x (Enterprise Value 5.05b / FCF TTM 294.0m)
FCF Yield = 5.82% (FCF TTM 294.0m / Enterprise Value 5.05b)
FCF Margin = 25.41% (FCF TTM 294.0m / Revenue TTM 1.16b)
Net Margin = 10.90% (Net Income TTM 126.1m / Revenue TTM 1.16b)
Gross Margin = 65.22% ((Revenue TTM 1.16b - Cost of Revenue TTM 402.3m) / Revenue TTM)
Gross Margin QoQ = 69.08% (prev 56.16%)
Tobins Q-Ratio = 0.87 (Enterprise Value 5.05b / Total Assets 5.84b)
Interest Expense / Debt = 5.35% (Interest Expense 79.9m / Debt 1.49b)
Taxrate = 27.64% (16.5m / 59.8m)
NOPAT = 203.0m (EBIT 280.6m * (1 - 27.64%))
Current Ratio = 1.76 (Total Current Assets 386.6m / Total Current Liabilities 220.0m)
Debt / Equity = 0.38 (Debt 1.49b / totalStockholderEquity, last quarter 3.94b)
Debt / EBITDA = 3.11 (Net Debt 1.33b / EBITDA 429.2m)
Debt / FCF = 4.53 (Net Debt 1.33b / FCF TTM 294.0m)
Total Stockholder Equity = 3.55b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.41% (Net Income 126.1m / Total Assets 5.84b)
RoE = 3.48% (Net Income TTM 126.1m / Total Stockholder Equity 3.62b)
RoCE = 5.53% (EBIT 280.6m / Capital Employed (Equity 3.62b + L.T.Debt 1.46b))
RoIC = 3.70% (NOPAT 203.0m / Invested Capital 5.48b)
WACC = 7.13% (E(3.72b)/V(5.21b) * Re(8.43%) + D(1.49b)/V(5.21b) * Rd(5.35%) * (1-Tc(0.28)))
Discount Rate = 8.43% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 87.41 | Cagr: 7.27%
[DCF] Terminal Value 77.97% ; FCFF base≈254.8m ; Y1≈292.1m ; Y5≈429.9m
[DCF] Fair Price = 26.78 (EV 6.47b - Net Debt 1.33b = Equity 5.14b / Shares 191.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.38 | # QB: 0
Revenue Correlation: 99.82 | Revenue CAGR: 17.28% | SUE: 0.25 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.40 | Chg30d=-1.02% | Revisions=-30% | Analysts=20
EPS next Quarter (2026-09-30): EPS=0.41 | Chg30d=-1.00% | Revisions=-22% | Analysts=20
EPS current Year (2026-12-31): EPS=1.64 | Chg30d=+0.85% | Revisions=+39% | GrowthEPS=+15.7% | GrowthRev=+16.9%
EPS next Year (2027-12-31): EPS=1.85 | Chg30d=-0.35% | Revisions=+18% | GrowthEPS=+12.5% | GrowthRev=+10.7%
[Analyst] Revisions Ratio: +39%